Position in NVS
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$21,016,152
-$552,148 QoQ
Shares Held
134,100
-5.0% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
2.36%
of 13F equity value
Holder Rank
#116
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ProVise Management Group, LLC holds $49,564,821 across 10 Drug Manufacturers - General names. NVS ranks #1 (42.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVS |
Novartis AG
This page
|
134,100 | $21,016,152 | |
| 2 | GSK |
GSK plc
|
123,527 | $6,475,285 | |
| 3 | AMGN |
Amgen Inc
|
16,496 | $5,973,531 | |
| 4 | SNY |
Sanofi
|
120,829 | $5,154,565 | |
| 5 | PFE |
Pfizer Inc
|
145,537 | $3,504,530 | |
| 6 | ABBV |
AbbVie Inc.
|
10,735 | $2,701,355 | |
| 7 | LLY |
ELI LILLY & Co
|
1,561 | $1,872,310 | |
| 8 | JNJ |
Johnson & Johnson
|
6,573 | $1,669,344 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,016,152 | 134,100 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $21,568,300 | 141,200 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $19,919,319 | 144,479 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $18,001,561 | 140,374 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $16,513,871 | 136,467 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $14,807,108 | 132,823 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $12,587,924 | 129,359 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $15,169,987 | 131,890 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $13,685,752 | 128,553 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $12,322,434 | 127,390 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $12,552,186 | 124,316 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $12,242,858 | 120,193 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $11,760,253 | 116,542 | Shares | Sole | 2023-08-24 | |
| 2023-03-31 | $10,452,028 | 113,609 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $10,255,170 | 113,042 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $8,002,788 | 105,286 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $8,191,717 | 96,909 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $7,857,135 | 89,540 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $7,683,977 | 87,847 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $6,884,485 | 84,183 | Shares | Sole | 2021-10-20 | |
| 2021-06-30 | $7,333,962 | 80,381 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $6,916,101 | 80,909 | Shares | Sole | 2021-04-22 | |
| 2020-12-31 | $7,623,806 | 80,735 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $6,920,276 | 79,580 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $6,984,143 | 79,965 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $6,750,428 | 81,873 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||